Eli Lilly and Co (NYSE:LLY) Stock Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/16/2024 | 21.39% | Morgan Stanley | $805 → $950 | Maintains | Overweight |
| 02/14/2024 | 4.14% | Cantor Fitzgerald | → $815 | Reiterates | Overweight → Overweight |
| 02/07/2024 | 8.61% | Truist Securities | $650 → $850 | Maintains | Buy |
| 02/07/2024 | 2.86% | Morgan Stanley | $763 → $805 | Maintains | Overweight |
| 02/07/2024 | 3.5% | Barclays | $680 → $810 | Maintains | Overweight |
| 02/07/2024 | 5.42% | Wells Fargo | $700 → $825 | Maintains | Overweight |
| 02/07/2024 | 10.53% | BMO Capital | $710 → $865 | Maintains | Outperform |
| 02/06/2024 | 5.42% | Wells Fargo | $700 → $825 | Maintains | Overweight |
| 02/06/2024 | 4.14% | Cantor Fitzgerald | $630 → $815 | Maintains | Overweight |
| 02/05/2024 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 02/01/2024 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 01/24/2024 | -10.56% | Wells Fargo | $650 → $700 | Maintains | Overweight |
| 01/23/2024 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 01/23/2024 | -13.11% | Barclays | $630 → $680 | Maintains | Overweight |
| 12/21/2023 | -22.06% | Daiwa Capital | → $610 | Downgrades | Buy → Outperform |
| 11/29/2023 | -16.95% | Truist Securities | → $650 | Reiterates | Buy → Buy |
| 11/20/2023 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 11/17/2023 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 11/15/2023 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 11/09/2023 | -31.64% | Deutsche Bank | → $535 | Initiates Coverage On | → Hold |
| 11/08/2023 | — | JP Morgan | Reiterates | → Overweight | |
| 11/03/2023 | -7.75% | Morgan Stanley | $673 → $722 | Maintains | Overweight |
| 10/23/2023 | -13.75% | Citigroup | $525 → $675 | Maintains | Buy |
| 10/23/2023 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 10/20/2023 | -9.28% | UBS | $612 → $710 | Assumes | Buy → Buy |
| 10/11/2023 | -14.01% | Morgan Stanley | $640 → $673 | Maintains | Overweight |
| 10/09/2023 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 10/09/2023 | -16.95% | Wells Fargo | $615 → $650 | Maintains | Overweight |
| 10/02/2023 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 09/05/2023 | -20.78% | Argus Research | $470 → $620 | Maintains | Buy |
| 09/05/2023 | -18.22% | Morgan Stanley | $617 → $640 | Maintains | Overweight |
| 09/05/2023 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 08/22/2023 | -19.5% | Cantor Fitzgerald | → $630 | Reiterates | Overweight → Overweight |
| 08/10/2023 | -39.95% | Goldman Sachs | $385 → $470 | Maintains | Neutral |
| 08/09/2023 | -29.72% | Cantor Fitzgerald | → $550 | Reiterates | Overweight → Overweight |
| 08/09/2023 | -23.33% | JP Morgan | $510 → $600 | Maintains | Overweight |
| 08/09/2023 | -24.61% | Barclays | $500 → $590 | Maintains | Overweight |
| 08/09/2023 | -39.95% | Goldman Sachs | $385 → $470 | Maintains | Neutral |
| 08/09/2023 | -19.12% | BMO Capital | $565 → $633 | Maintains | Outperform |
| 08/09/2023 | -23.33% | Truist Securities | $525 → $600 | Maintains | Buy |
| 08/09/2023 | -25.89% | Credit Suisse | $490 → $580 | Maintains | Outperform |
| 08/09/2023 | -21.16% | Morgan Stanley | $560 → $617 | Maintains | Overweight |
| 08/09/2023 | -25.89% | RBC Capital | $490 → $580 | Maintains | Outperform |
| 08/09/2023 | -21.42% | Jefferies | → $615 | Upgrades | Hold → Buy |
| 08/08/2023 | -21.42% | Wells Fargo | $500 → $615 | Maintains | Overweight |
| 07/28/2023 | -34.83% | JP Morgan | $475 → $510 | Maintains | Overweight |
| 07/26/2023 | -32.92% | Citigroup | $360 → $525 | Maintains | Buy |
| 07/21/2023 | -45.06% | Jefferies | $408 → $430 | Maintains | Hold |
| 07/21/2023 | -28.45% | Morgan Stanley | $551 → $560 | Maintains | Overweight |
| 07/20/2023 | -32.92% | Truist Securities | $430 → $525 | Maintains | Buy |
| 07/17/2023 | -29.72% | Cantor Fitzgerald | → $550 | Reiterates | Overweight → Overweight |
| 07/14/2023 | -28.45% | HSBC | → $560 | Initiates Coverage On | → Buy |
| 07/13/2023 | -29.72% | Cantor Fitzgerald | → $550 | Reiterates | Overweight → Overweight |
| 07/11/2023 | -29.6% | Morgan Stanley | $507 → $551 | Maintains | Overweight |
| 06/27/2023 | -29.72% | Cantor Fitzgerald | $485 → $550 | Maintains | Overweight |
| 06/27/2023 | -45.06% | Truist Securities | → $430 | Reiterates | Buy → Buy |
| 06/20/2023 | -38.03% | Cantor Fitzgerald | → $485 | Reiterates | Overweight → Overweight |
| 05/26/2023 | -38.03% | Cantor Fitzgerald | → $485 | Reiterates | Overweight → Overweight |
| 05/26/2023 | -36.11% | Wells Fargo | $440 → $500 | Maintains | Overweight |
| 05/24/2023 | -36.11% | B of A Securities | $450 → $500 | Maintains | Buy |
| 05/23/2023 | -36.11% | TD Cowen | $430 → $500 | Maintains | Outperform |
| 05/22/2023 | -38.03% | Cantor Fitzgerald | $485 → $485 | Reiterates | Overweight → Overweight |
| 05/15/2023 | -35.22% | Morgan Stanley | $478 → $507 | Maintains | Overweight |
| 05/04/2023 | -35.47% | BMO Capital | $430 → $505 | Maintains | Outperform |
| 05/04/2023 | -39.31% | JP Morgan | $430 → $475 | Maintains | Overweight |
| 05/04/2023 | -37.39% | Credit Suisse | $420 → $490 | Maintains | Outperform |
| 05/01/2023 | -41.48% | SVB Securities | $410 → $458 | Maintains | Outperform |
| 05/01/2023 | -46.33% | Barclays | $400 → $420 | Maintains | Overweight |
| 04/28/2023 | -45.06% | JP Morgan | $400 → $430 | Maintains | Overweight |
| 04/28/2023 | -38.03% | Cantor Fitzgerald | $432 → $485 | Maintains | Overweight |
| 04/28/2023 | -38.92% | Morgan Stanley | $445 → $478 | Maintains | Overweight |
| 04/28/2023 | -46.33% | Credit Suisse | $400 → $420 | Maintains | Outperform |
| 04/28/2023 | -43.78% | Wells Fargo | $375 → $440 | Maintains | Overweight |
| 04/14/2023 | -43.14% | Morgan Stanley | $448 → $445 | Maintains | Overweight |
| 04/11/2023 | -49.91% | Guggenheim | $395 → $392 | Maintains | Buy |
| 04/10/2023 | -42.76% | Morgan Stanley | $444 → $448 | Maintains | Overweight |
| 04/03/2023 | -60.39% | Jefferies | $290 → $310 | Maintains | Hold |
| 03/13/2023 | -52.08% | Wells Fargo | $360 → $375 | Upgrades | Equal-Weight → Overweight |
| 03/06/2023 | -62.94% | Jefferies | → $290 | Initiates Coverage On | → Hold |
| 03/03/2023 | -54% | Citigroup | $370 → $360 | Maintains | Buy |
| 03/01/2023 | -43.27% | Morgan Stanley | $455 → $444 | Maintains | Overweight |
| 02/16/2023 | -64.48% | Societe Generale | → $278 | Downgrades | Hold → Sell |
| 02/03/2023 | -54% | Wells Fargo | $375 → $360 | Maintains | Equal-Weight |
| 02/03/2023 | -41.86% | Morgan Stanley | $440 → $455 | Maintains | Overweight |
| 01/03/2023 | -48.89% | Barclays | $395 → $400 | Maintains | Overweight |
| 12/16/2022 | -47.61% | SVB Leerink | $384 → $410 | Maintains | Outperform |
| 12/15/2022 | -46.33% | UBS | $428 → $420 | Maintains | Buy |
| 12/14/2022 | -43.78% | Morgan Stanley | $446 → $440 | Maintains | Overweight |
| 12/08/2022 | -52.08% | Wells Fargo | $365 → $375 | Maintains | Equal-Weight |
| 12/07/2022 | -48.76% | Guggenheim | $399 → $401 | Maintains | Buy |
| 12/06/2022 | -43.01% | Morgan Stanley | $436 → $446 | Maintains | Overweight |
| 12/06/2022 | -48.89% | Credit Suisse | $395 → $400 | Maintains | Outperform |
| 12/05/2022 | -45.06% | Cowen & Co. | $390 → $430 | Maintains | Outperform |
| 11/22/2022 | -52.08% | Berenberg | $345 → $375 | Maintains | Buy |
| 11/18/2022 | -49.53% | Credit Suisse | → $395 | Initiates Coverage On | → Outperform |
| 11/17/2022 | -44.29% | Morgan Stanley | $441 → $436 | Maintains | Overweight |
| 11/08/2022 | -60.01% | Goldman Sachs | $281 → $313 | Maintains | Neutral |
| 11/02/2022 | -53.36% | Wells Fargo | $305 → $365 | Maintains | Equal-Weight |
| 11/02/2022 | -49.53% | Barclays | $355 → $395 | Maintains | Overweight |
| 11/02/2022 | -43.65% | Morgan Stanley | $408 → $441 | Maintains | Overweight |
| 11/02/2022 | -50.93% | SVB Leerink | $341 → $384 | Maintains | Outperform |
| 10/12/2022 | -47.87% | Morgan Stanley | $412 → $408 | Maintains | Overweight |
| 09/22/2022 | -53.62% | UBS | → $363 | Upgrades | Neutral → Buy |
| 09/07/2022 | -47.36% | Morgan Stanley | $395 → $412 | Maintains | Overweight |
| 09/06/2022 | -49.4% | BMO Capital | $369 → $396 | Maintains | Outperform |
| 07/08/2022 | -49.53% | Morgan Stanley | $369 → $395 | Maintains | Overweight |
| 07/07/2022 | -54.64% | Barclays | $333 → $355 | Maintains | Overweight |
| 06/01/2022 | -54.64% | JP Morgan | $340 → $355 | Maintains | Overweight |
| 05/23/2022 | -56.43% | SVB Leerink | → $341 | Initiates Coverage On | → Outperform |
| 05/02/2022 | -54.51% | Mizuho | $315 → $356 | Maintains | Buy |
| 04/29/2022 | -54.26% | BMO Capital | $330 → $358 | Maintains | Outperform |
| 04/29/2022 | -52.85% | Morgan Stanley | $364 → $369 | Maintains | Overweight |
| 04/29/2022 | -61.03% | Wells Fargo | $280 → $305 | Maintains | Equal-Weight |
| 04/12/2022 | -66.27% | Goldman Sachs | $234 → $264 | Maintains | Neutral |
| 04/06/2022 | -53.49% | Morgan Stanley | $265 → $364 | Maintains | Overweight |
| 02/04/2022 | -66.14% | Morgan Stanley | $272 → $265 | Maintains | Overweight |
| 02/04/2022 | -62.56% | Mizuho | $302 → $293 | Maintains | Buy |
| 01/24/2022 | -65.24% | Morgan Stanley | $275 → $272 | Maintains | Overweight |
| 01/21/2022 | -62.82% | DZ Bank | → $291 | Upgrades | Hold → Buy |
| 01/04/2022 | -64.22% | Wells Fargo | $270 → $280 | Maintains | Equal-Weight |
| 12/20/2021 | -58.47% | Barclays | $280 → $325 | Maintains | Overweight |
| 12/20/2021 | -61.03% | Berenberg | $270 → $305 | Maintains | Buy |
| 12/17/2021 | -69.84% | Goldman Sachs | → $236 | Initiates Coverage On | → Neutral |
| 12/09/2021 | -65.5% | Wells Fargo | → $270 | Initiates Coverage On | → Equal-Weight |
| 11/19/2021 | -60.26% | BMO Capital | → $311 | Initiates Coverage On | → Outperform |
| 10/11/2021 | -65.5% | Berenberg | $240 → $270 | Upgrades | Hold → Buy |
| 09/29/2021 | -66.14% | Citigroup | $210 → $265 | Upgrades | Neutral → Buy |
| 08/30/2021 | -61.67% | Cowen & Co. | $250 → $300 | Maintains | Outperform |
| 08/05/2021 | -64.86% | Morgan Stanley | $207 → $275 | Maintains | Overweight |
| 08/05/2021 | -63.2% | DZ Bank | → $288 | Upgrades | Hold → Buy |
| 08/04/2021 | -64.35% | Mizuho | $250 → $279 | Maintains | Buy |
| 08/04/2021 | -64.86% | Morgan Stanley | $207 → $275 | Maintains | Overweight |
| 07/06/2021 | -68.06% | Barclays | $227 → $250 | Maintains | Overweight |
| 07/02/2021 | -66.52% | Truist Securities | $225 → $262 | Maintains | Buy |
| 06/24/2021 | -61.67% | Cantor Fitzgerald | $245 → $300 | Maintains | Overweight |
| 06/24/2021 | -68.06% | Cowen & Co. | $235 → $250 | Maintains | Outperform |
| 06/15/2021 | -66.78% | JP Morgan | $240 → $260 | Maintains | Overweight |
| 06/14/2021 | -65.5% | Goldman Sachs | $252 → $270 | Maintains | Buy |
| 04/28/2021 | -73.55% | Morgan Stanley | $217 → $207 | Maintains | Overweight |
| 04/28/2021 | -72.4% | Mizuho | $228 → $216 | Maintains | Buy |
| 04/28/2021 | -70.99% | Barclays | $232 → $227 | Maintains | Overweight |
| 03/15/2021 | -71.25% | Truist Securities | $215 → $225 | Maintains | Buy |
| 02/12/2021 | -69.97% | Cowen & Co. | $195 → $235 | Maintains | Outperform |
| 02/04/2021 | -72.27% | Morgan Stanley | $190 → $217 | Maintains | Overweight |
| 02/01/2021 | -72.53% | Truist Securities | $200 → $215 | Maintains | Buy |
| 02/01/2021 | -70.87% | Mizuho | $222 → $228 | Maintains | Buy |
| 01/22/2021 | -71.25% | B of A Securities | $195 → $225 | Maintains | Buy |
| 01/19/2021 | -71.63% | Mizuho | $164 → $222 | Upgrades | Neutral → Buy |
| 12/10/2020 | -76.62% | Wolfe Research | $147 → $183 | Upgrades | Peer Perform → Outperform |
| 11/17/2020 | -80.07% | Mizuho | $164 → $156 | Maintains | Neutral |
| 11/10/2020 | -80.83% | Bernstein | → $150 | Initiates Coverage On | → Market Perform |
| 10/28/2020 | -78.28% | Morgan Stanley | $176 → $170 | Maintains | Overweight |
| 10/23/2020 | -77% | Truist Securities | → $180 | Initiates Coverage On | → Buy |
| 10/16/2020 | -74.44% | JP Morgan | $190 → $200 | Maintains | Overweight |
| 09/29/2020 | -81.6% | Berenberg | → $144 | Initiates Coverage On | → Hold |
| 09/03/2020 | -77.51% | Morgan Stanley | → $176 | Upgrades | Equal-Weight → Overweight |
| 08/14/2020 | -79.94% | Morgan Stanley | $148 → $157 | Maintains | Equal-Weight |
| 06/19/2020 | -77% | B of A Securities | $165 → $180 | Maintains | Buy |
| 06/17/2020 | -75.72% | JP Morgan | $175 → $190 | Maintains | Overweight |
| 04/24/2020 | -78.66% | CFRA | $146 → $167 | Maintains | Hold |
| 04/21/2020 | -79.81% | UBS | $157 → $158 | Downgrades | Buy → Neutral |
| 04/15/2020 | -79.56% | Cowen & Co. | $145 → $160 | Maintains | Outperform |
| 04/09/2020 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
| 04/02/2020 | -81.09% | Morgan Stanley | $150 → $148 | Maintains | Overweight |
| 03/11/2020 | -78.53% | Goldman Sachs | → $168 | Maintains | Buy |
| 02/06/2020 | -81.09% | Mizuho | → $148 | Initiates Coverage On | → Neutral |
| 12/30/2019 | -78.92% | Argus Research | $145 → $165 | Maintains | Buy |
| 12/18/2019 | -80.83% | JP Morgan | $140 → $150 | Maintains | Overweight |
| 12/18/2019 | -80.83% | Morgan Stanley | $116 → $150 | Upgrades | Equal-Weight → Overweight |
| 10/17/2019 | -83.01% | UBS | $134 → $133 | Maintains | Buy |
| 10/17/2019 | -83.01% | B of A Securities | → $133 | Reinstates | → Buy |
| 09/10/2019 | -84.67% | B of A Securities | $118 → $120 | Reiterates | → Neutral |
| 05/28/2019 | -82.75% | Goldman Sachs | → $135 | Initiates Coverage On | → Buy |
| 05/01/2019 | -83.01% | BMO Capital | $130 → $133 | Maintains | Outperform |
| 04/24/2019 | — | Edward Jones | Upgrades | Hold → Buy | |
| 04/11/2019 | — | Guggenheim | Downgrades | Buy → Neutral |